Cary Vance was named President and Chief Executive Officer of AVITA Medical, Inc., effective April 30, 2026. As of November 6, 2026, AVITA Medical, Inc. has reported one leadership change filing to the SEC under Item 5.02 of Form 8-K, on May 1, 2026, naming 1 appointment (Form 8-K, May 1, 2026).
30 companies changed executives this week.
Companies that just changed executives, and the new executive. Before you unlock: the company, the change and what is inside. After: the executive named with their role, how to reach the company, and a person's email only when we found one.
| John Hancock Comvest Private Income Fund | named a new Chief Financial Officer | |
| Bain Capital Specialty Finance, Inc. | named a new Director | |
| Azora Therapeutics, Inc. (DE) | named a new Director | |
| LASE Corp. | named a new Director | |
| Century Communities, Inc. | named a new Executive Chairman |
Sell to companies like AVITA Medical, Inc? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
AVITA Medical, Inc. reported a change among its directors and officers to the SEC on Form 8-K, Item 5.02, on 2026-05-01. It names 1 person. Every row below is cited to the filing it comes from, and this page adds each new change as AVITA Medical, Inc. files it.
Timeline
| Filed | In / out | Person | Role | Effective | Source |
|---|---|---|---|---|---|
| 2026-05-01 | In | President and Chief Executive Officer | 2026-04-30 | 8-K, 2026-05-01 |
Selling to them or working with them? See who runs AVITA Medical, Inc. now and the warning signs.
Free to see. No signup.
Watch AVITA Medical, Inc.
Get an email when AVITA Medical, Inc. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on AVITA Medical, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on AVITA Medical, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on AVITA Medical, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
1 cited source found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Who leads AVITA Medical, Inc., as last reported?
For each role that changed in the filings below, the most recent change reported. A role that did not change in these filings is not listed.
- President and Chief Executive Officer: Cary Vance, appointed, effective 2026-04-30 (filed 2026-05-01).
New leaders reset buying decisions — get the Full Report on AVITA Medical, Inc.: who runs it, how the money works and what to watch, every claim linked to its source.
Get the Full ReportFind people with the same kind of experience as the President and Chief Executive Officer at AVITA Medical, Inc., with the record behind each one.
Find candidates like President and Chief Executive Officer at AVITA Medical, Inc.Every change, in the filing's words
Appointed: Cary Vance, President and Chief Executive Officer, effective 2026-04-30
On April 29, 2026, the Board of Directors (the "Board") of AVITA Medical, Inc (the "Company") appointed Cary Vance as President and Chief Executive Officer ("CEO"), effective April 30, 2026 (the "Effective Date").
- Appointments of President and Chief Executive Officer and Chair of the Board of Directors.
- Mr. Vance will continue to serve as an executive member of the Board, while the Board appointed Jan Stern Reed as Chair of the Board while simultaneously terminating the Lead Independent Director position that she had been serving since October 2025.
- Mr. Vance, age 60, has served as a Director of the Company since April 2023, as Chairman of the Board from August 2025 to October 2025, and as Interim CEO and Executive Chairman of the Board since October 2025.
- Upon his appointment as Interim CEO, Mr. Vance stepped down from serving as a member of both the Audit and Nominating and Corporate Governance Committees of the Board, and as Chair of the Human Capital and Compensation Committee.
- Mr. Vance has 30 years of leadership experience with commercial and operational expertise in the healthcare industry.
- He was most recently the President and Chief Executive Officer of PhotoniCare, Inc., a medical technology company developing diagnostic imaging solutions for otolaryngology.
- Prior to this appointment, he was President and Chief Executive Officer of Titan Medical Inc., a medical-device company based in Canada focused on robotic-assisted surgery, and also served as an independent director on Titan Medical's Board of Directors until November 2024.
Tools for this story
Each opens in a new tab, filled in for AVITA Medical, Inc.. With no account yet, you sign up free and land on the result.
Where this comes from
A public company must file a current report on Form 8-K with the SEC within four business days when a director leaves or is elected, or when its chief executive, chief financial, chief accounting or chief operating officer, or another named executive, departs or is appointed. That disclosure goes under Item 5.02 of the report.
Every change on this page is taken from one of those filings and quoted in the company's own words, with a link to the filing, so it can be checked at the source. Where a filing names the person, the role and the date a change takes effect, they are shown beside the quote. Where it does not, the quote stands on its own. A filing states what changed; it rarely states why, and neither does this page.